Suriname

Latin America

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Suriname is regulated by the Bureau of Public Health. The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

Bureau of Public Health

Regulatory Pathways (1)

Suriname MOH Special Import Authorization 45 days

Suriname Ministry of Health special import authorization for unregistered medicines for patients with serious or life-threatening conditions.

Application Form: MOH Suriname Special Import Form

Legal Basis: Regulated

Eligibility: Serious or life-threatening condition with no locally registered alternative

Suriname

ISO Code	`SR`
Region	Latin America
Regulatory Authority	Bureau of Public Health
Pathways	1 documented
Drugs Available	0 documented